In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer"

Luca F Valle; Nicholas G Nickols; Kosj Yamoah; Isla P Garraway; Kara N Maxwell; Julie A Lynch

doi:10.1093/oncolo/oyad264

In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer"

Oncologist. 2023 Nov 2;28(11):e1129-e1130. doi: 10.1093/oncolo/oyad264.

Authors

Luca F Valle^{1

2}, Nicholas G Nickols^{1

2

3

4}, Kosj Yamoah^{5

6}, Isla P Garraway^{1

3

4}, Kara N Maxwell^{7

8

9}, Julie A Lynch^{10

11

12}

Affiliations

¹ Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
² Department of Radiation Oncology, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA.
³ UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
⁴ Department of Urology, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
⁵ Department of Radiation Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
⁶ James A. Haley Veterans' Hospital, Tampa, FL, USA.
⁷ Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
⁸ Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
⁹ Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
¹⁰ Department of Veterans Affairs Informatics and Computing Infrastructure, Department of Veterans Affairs Salt Lake City Health Care System, Salt Lake City, UT, USA.
¹¹ Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
¹² Department of Nursing and Health Sciences, University of Massachusetts, Boston, MA, USA.

Abstract

This letter to the editor responds to comments by Sartor et al regarding recent findings on the clinical relevance of CDK12 pathogenic mutations.

Publication types

Editorial
Comment

MeSH terms

Cyclin-Dependent Kinases / genetics
Genomics
Humans
Male
Mutation
Prostatic Neoplasms* / pathology
Veterans*

Substances

CDK12 protein, human
Cyclin-Dependent Kinases

Abstract

Publication types

MeSH terms

Substances

Grants and funding